HOMER1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.755400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.490600E-01
Normal-vs-Stage2
5.692000E-01
Normal-vs-Stage3
5.347200E-01
Normal-vs-Stage4
3.388200E-01
Stage1-vs-Stage2
4.001400E-01
Stage1-vs-Stage3
8.156300E-02
Stage1-vs-Stage4
5.386600E-01
Stage2-vs-Stage3
1.140350E-02
Stage2-vs-Stage4
4.027200E-01
Stage3-vs-Stage4
2.119000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.729400E-01
Normal-vs-AfricanAmerican
4.462200E-01
Normal-vs-Asian
9.315200E-01
Caucasian-vs-AfricanAmerican
5.839800E-01
Caucasian-vs-Asian
3.759800E-01
AfricanAmerican-vs-Asian
3.256000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.751200E-01
Normal-vs-Female
5.669800E-01
Male-vs-Female
8.160000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.594600E-01
Normal-vs-Age(41-60Yrs)
3.040000E-01
Normal-vs-Age(61-80Yrs)
7.655000E-01
Normal-vs-Age(81-100Yrs)
7.606800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.629000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.392400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.877600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.924300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.199650E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.809200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.175800E-01
Normal-vs-Daily Drinker
8.650200E-01
Normal-vs-Weekly Drinker
5.980000E-01
Normal-vs-Occasional Drinker
2.848600E-01
Normal-vs-Social Drinker
4.358000E-01
Non Drinker-vs-Daily Drinker
8.087200E-01
Non Drinker-vs-Weekly Drinker
4.925400E-01
Non Drinker-vs-Occasional Drinker
1.334160E-01
Non Drinker-vs-Social Drinker
3.319200E-01
Daily Drinker-vs-Weekly Drinker
3.459200E-01
Daily Drinker-vs-Occasional Drinker
5.469900E-02
Daily Drinker-vs-Social Drinker
1.839830E-01
Weekly Drinker-vs-Occasional Drinker
5.779400E-01
Weekly Drinker-vs-Social Drinker
8.642400E-01
Occasional Drinker-vs-Social Drinker
6.661200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.953000E-01
Normal-vs-Grade 2
1.764000E-01
Normal-vs-Grade 3
1.000990E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.097400E-01
Grade 1-vs-Grade 3
3.364800E-01
Grade 1-vs-Grade 4
2.953000E-01
Grade 2-vs-Grade 3
2.963000E-01
Grade 2-vs-Grade 4
1.764000E-01
Grade 3-vs-Grade 4
1.000990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.919600E-01
Normal-vs-NonDiabetic
6.907000E-01
Diabetic-vs-NonDiabetic
3.693200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.763200E-01
Normal-vs-NoPancreatitis
6.197600E-01
Pancreatitis-vs-NoPancreatitis
5.916400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.749800E-01
Normal-vs-N1
5.341400E-01
N0-vs-N1
1.661170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.019800E-01
Normal-vs-TP53-NonMutant
7.384800E-01
TP53-Mutant-vs-TP53-NonMutant
7.004800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
